Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop and commercialize innovative therapeutic and diagnostic products for cancer and diseases of the central nervous system.
We perform our in-house research and development activities at our 11,000 square foot facility in Gaithersburg, Maryland.
Panacea Laboratories, a division of Panacea Pharmaceuticals, Inc., is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high complexity testing.
COMPANY HISTORY
Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop, and commercialize novel therapeutic and diagnostic products for cancer and diseases of the central nervous system and cancer.
The Company's core technologies exploit changes in disease-relevant proteins by altered expression, post-translational modification, and functional variation.
The Company also conducts research through Collaborative Research and other agreements with M.D. Anderson Cancer Center in Houston, Texas; Massachusetts Institute of Technology in Cambridge, Massachusetts; and Rhode Island Hospital/Brown University in Providence, Rhode Island where teams of researchers are continuing advances on the Company's core technologies.
Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop and commercialize innovative therapeutic and diagnostic products for cancer and diseases of the central nervous system.